Newton, MA, United States of America

Bin Feng

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 7.8

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • N. Reading, MA (US) (2009 - 2010)
  • North Reading, MA (US) (2018)
  • Newton, MA (US) (2017 - 2023)

Company Filing History:


Years Active: 2009-2023

Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: The Innovations of Bin Feng: Pioneering Anti-PD-1 Antibodies

Introduction

Bin Feng, an accomplished inventor based in Newton, MA, has made significant contributions to the field of biotechnology. He holds a remarkable total of seven patents, showcasing his innovative spirit and dedication to scientific advancement. His work primarily focuses on the development of anti-PD-1 antibodies, which play a crucial role in cancer treatment.

Latest Patents

Among Bin Feng's notable inventions are his latest patents concerning anti-PD-1 antibodies. These antibodies are engineered to bind to programmed cell death protein 1 (PD-1), a pivotal protein involved in immune response regulation. His patents cover the compositions comprising these antibodies, along with methods for their production and potential therapeutic applications. This advancement represents a significant stride in immuno-oncology, offering new avenues for treating various cancers.

Career Highlights

Bin Feng's professional journey has seen him contribute his expertise to esteemed organizations such as Aveo Pharmaceuticals, Inc. and Pd-1 Acquisition Group, LLC. Through his work in these companies, he has played a vital role in pushing the boundaries of cancer therapeutics and has garnered recognition as a leading inventor in the field.

Collaborations

Throughout his career, Bin Feng has collaborated with several talented colleagues, including Maria Isabel Chiu and Najmia Amirina. These partnerships have facilitated the exchange of ideas and fostered innovation, allowing them to collectively advance research in cancer treatment and therapeutic antibody development.

Conclusion

Bin Feng's innovative contributions to the biotechnology sector, particularly in the realm of anti-PD-1 antibodies, underscore his commitment to improving patient outcomes in cancer care. With a growing portfolio of patents and collaborations with distinguished peers, he continues to be a significant figure in the ongoing fight against cancer. His work exemplifies the impact of dedicated inventors on public health and medical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…